[1]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. https://doi.org/10.3322/caac.21660
|
[2]
|
Lopez, M.J., Carbajal, J., Alfaro, A.L., et al. (2023) Characteristics of Gastric Cancer around the World. Critical Reviews in Oncology/Hematology, 181, Article ID: 103841. https://doi.org/10.1016/j.critrevonc.2022.103841
|
[3]
|
Chen, W., Zheng, R., Baade, P.D., et al. (2016) Cancer Statistics in China, 2015. CA: A Cancer Journal for Clinicians, 66, 115-132. https://doi.org/10.3322/caac.21338
|
[4]
|
张思维, 郑荣寿, 孙可欣, 等. 2016年中国恶性肿瘤分地区发病和死亡估计: 基于人群的肿瘤登记数据分析[J]. 中国肿瘤, 2023, 32(5): 321-332.
|
[5]
|
Abbasi, S.Y., Taani, H.E., Saad, A., et al. (2011) Advanced Gastric Cancer in Jordan from 2004 to 2008: A Study of Epidemiology and Outcomes. Gastrointestinal Cancer Research Program, 4, 122-127.
|
[6]
|
Thomassen, I., Van Gestel, Y.R., Van Ramshorst, B., et al. (2014) Peritoneal Carcinomatosis of Gastric Origin: A Population-Based Study on Incidence, Survival and Risk Factors. International Journal of Cancer, 134, 622-628. https://doi.org/10.1002/ijc.28373
|
[7]
|
Wu, C.W., Lo, S.S., Shen, K.H., et al. (2003) Incidence and Factors Associated with Recurrence Patterns after Intended Curative Surgery for Gastric Cancer. World Journal of Surgery, 27, 153-158. https://doi.org/10.1007/s00268-002-6279-7
|
[8]
|
Sasako, M., Sano, T., Yamamoto, S., et al. (2008) D2 Lymphadenectomy Alone or with Para-Aortic Nodal Dissection for Gastric Cancer. The New England Journal of Medicine, 359, 453-462. https://doi.org/10.1056/NEJMoa0707035
|
[9]
|
Spolverato, G., Ejaz, A., Kim, Y., et al. (2014) Rates and Patterns of Recurrence after Curative Intent Resection for Gastric Cancer: A United States Multi-Institutional Analysis. Journal of the American College of Surgeons, 219, 664-675. https://doi.org/10.1016/j.jamcollsurg.2014.03.062
|
[10]
|
Chau, I., Norman, A.R., Cunningham, D., et al. (2004) Multivariate Prognostic Factor Analysis in Locally Advanced and Metastatic Esophago-Gastric Cancer—Pooled Analysis from Three Multicenter, Randomized, Controlled Trials Using Individual Patient Data. Journal of Clinical Oncology, 22, 2395-2403. https://doi.org/10.1200/JCO.2004.08.154
|
[11]
|
Kim, J.G., Ryoo, B.Y., Park, Y.H., et al. (2008) Prognostic Factors for Survival of Patients with Advanced Gastric Cancer Treated with Cisplatin-Based Chemotherapy. Cancer Chemotherapy and Pharmacology, 61, 301-307. https://doi.org/10.1007/s00280-007-0476-x
|
[12]
|
Rau, B., Brandl, A., Thuss-Patience, P., et al. (2019) the Efficacy of Treatment Options for Patients with Gastric Cancer and Peritoneal Metastasis. Gastric Cancer, 22, 1226-1237. https://doi.org/10.1007/s10120-019-00969-1
|
[13]
|
Yarema, R., Mielko, J., Fetsych, T., et al. (2019) Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Combined Treatment of Locally Advanced and Intraperitonealy Disseminated Gastric Cancer: A Retrospective Cooperative Central-Eastern European Study. Cancer Medicine, 8, 2877-2885. https://doi.org/10.1002/cam4.2204
|
[14]
|
Brenkman, H.J, F., Päeva, M., Van, Hillegersberg, R., et al. (2019) Prophylactic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer—A Systematic Review. Journal of Clinical Medicine, 8, Article 1685. https://doi.org/10.3390/jcm8101685
|
[15]
|
Diniz, T.P., Da Costa Jr., W.L., Fonseca De Jesus, V.H., et al. (2020) Does Hipec Improve Outcomes in Gastric Cancer Patients Treated with Perioperative Chemotherapy and Radical Surgery? A Propensity-Score Matched Analysis. Journal of Surgical Oncology, 121, 823-832. https://doi.org/10.1002/jso.25823
|
[16]
|
Xie, T.Y., Wu, D., Li, S., et al. (2020) Role of Prophylactic Hyperthermic Intraperitoneal Chemotherapy in Patients with Locally Advanced Gastric Cancer. World Journal of Gastrointestinal Oncology, 12, 782-790. https://doi.org/10.4251/wjgo.v12.i7.782
|
[17]
|
Roviello, F., Caruso, S., Neri, A., et al. (2013) Treatment and Prevention of Peritoneal Carcinomatosis from Gastric Cancer by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Overview and Rationale. European Journal of Surgical Oncology, 39, 1309-1316. https://doi.org/10.1016/j.ejso.2013.10.010
|
[18]
|
Zhu, L., Xu, Z., Wu, Y., et al. (2020) Prophylactic Chemotherapeutic Hyperthermic Intraperitoneal Perfusion Reduces Peritoneal Metastasis in Gastric Cancer: A Retrospective Clinical Study. BMC Cancer, 20, Article No. 827. https://doi.org/10.1186/s12885-020-07339-6
|
[19]
|
Spratt, J.S., Adcock, R.A., Muskovin, M., et al. (1980) Clinical Delivery System for Intraperitoneal Hyperthermic Chemotherapy. Cancer Research, 40, 256-260.
|
[20]
|
Fujimoto, S., Shrestha, R.D., Kokubun, M., et al. (1988) Intraperitoneal Hyperthermic Perfusion Combined with Surgery Effective for Gastric Cancer Patients with Peritoneal Seeding. Annals of Surgery, 208, 36-41. https://doi.org/10.1097/00000658-198807000-00005
|
[21]
|
崔书中, 巴明臣, 唐鸿生. 腹腔热灌注化疗技术方法变迁及展望[J]. 中华临床医师杂志(电子版), 2011, 5(7): 2039-2042.
|
[22]
|
Glehen, O., Cotte, E., Kusamura, S., et al. (2008) Hyperthermic Intraperitoneal Chemotherapy: Nomenclature and Modalities of Perfusion. Journal of Surgical Oncology, 98, 242-246. https://doi.org/10.1002/jso.21061
|
[23]
|
Ba, M., Long, H., Zhang, X., et al. (2014) Different Sequential Approaches of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Treating Ovarian Cancer with Malignant Ascites. Journal of Cancer Research and Clinical Oncology, 140, 1497-1506. https://doi.org/10.1007/s00432-014-1692-5
|
[24]
|
Cravioto-Villanueva, A., Cavazos, M., Luna-Perez, P., et al. (2016) Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Delivered via a Modified Perfusion System for Peritoneal Carcinomatosis of Colorectal Origin. Surgery Today, 46, 979-984. https://doi.org/10.1007/s00595-016-1335-3
|
[25]
|
崔书中, 巴明臣, 黄迪文, 等. BR-TRG-I型体腔热灌注治疗系统的研制与开发[J]. 中国医疗设备, 2009, 24(9): 7-9.
|
[26]
|
张楠, 陈凛, 张勇. 高精度热灌注系统治疗腹腔恶性肿瘤的应用研究[J]. 医疗卫生装备, 2012, 33(5): 74-75.
|
[27]
|
崔书中, 巴明臣, 黄狄文, 等. BR-TRG-I型体腔热灌注治疗系统安全性评估的动物实验[J]. 中国比较医学杂志, 2009, 19(10): 27-31, 79.
|
[28]
|
Kok, H.P., Beck, M., Löke, D.R., et al. (2020) Locoregional Peritoneal Hyperthermia to Enhance the Effectiveness of Chemotherapy in Patients with Peritoneal Carcinomatosis: A Simulation Study Comparing Different Locoregional Heating Systems. International Journal of Hyperthermia, 37, 76-88. https://doi.org/10.1080/02656736.2019.1710270
|
[29]
|
Helderman, R., Löke, D.R., Verhoeff, J.,, et al. (2020) the Temperature-Dependent Effectiveness of Platinum-Based Drugs Mitomycin-C and 5-FU During Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Cell Lines. Cells, 9, Article 1775. https://doi.org/10.3390/cells9081775
|
[30]
|
Löke, D.R., Helderman, R., Franken, N.A.P., et al. (2021) Simulating Drug Penetration during Hyperthermic Intraperitoneal Chemotherapy. Drug Delivery, 28, 145-161. https://doi.org/10.1080/10717544.2020.1862364
|
[31]
|
Repasky, E.A., Evans, S.S. and Dewhirst, M.W. (2013) Temperature Matters! And Why It Should Matter to Tumor Immunologists. Cancer Immunology Research, 1, 210-216. https://doi.org/10.1158/2326-6066.CIR-13-0118
|
[32]
|
Nigg, E.A., Čajánek, L. and Arquint, C. (2014) The Centrosome Duplication Cycle in Health and Disease. FEBS Letters, 588, 2366-2372. https://doi.org/10.1016/j.febslet.2014.06.030
|
[33]
|
Dyson, J.E., Simmons, D.M., Daniel, J., et al. (1986) Kinetic and Physical Studies of Cell Death Induced by Chemotherapeutic Agents Or Hyperthermia. Cell Proliferation, 19, 311-324. https://doi.org/10.1111/j.1365-2184.1986.tb00683.x
|
[34]
|
Pelz, J.O., Vetterlein, M., Grimmig, T., et al. (2013) Hyperthermic Intraperitoneal Chemotherapy in Patients with Peritoneal Carcinomatosis: Role of Heat Shock Proteins and Dissecting Effects of Hyperthermia. Annals of Surgical Oncology, 20, 1105-1113. https://doi.org/10.1245/s10434-012-2784-6
|
[35]
|
Kusamura, S., Dominique, E., Baratti, D., et al. (2008) Drugs, Carrier Solutions and Temperature in Hyperthermic Intraperitoneal Chemotherapy. Journal of Surgical Oncology, 98, 247-252. https://doi.org/10.1002/jso.21051
|
[36]
|
Ruan, Q., Fang, Z.Y., Cui, S.Z., et al. (2015) Thermo-Chemotherapy Induced MiR-218 Upregulation Inhibits the Invasion of Gastric Cancer via Targeting Gli2 and E-Cadherin. Tumor Biology, 36, 5807-5814. https://doi.org/10.1007/s13277-015-3250-4
|
[37]
|
Van Stein, R.M., Aalbers, A.G.J., Sonke, G.S., et al. (2021) Hyperthermic Intraperitoneal Chemotherapy for Ovarian and Colorectal Cancer: A Review. JAMA Oncology, 7, 1231-1238. https://doi.org/10.1001/jamaoncol.2021.0580
|
[38]
|
Bhatt, A., De,Hingh, I., Van Der Speeten, K., et al. (2021) HIPEC Methodology and Regimens: The Need for an Expert Consensus. Annals of Surgical Oncology, 28, 9098-9113. https://doi.org/10.1245/s10434-021-10193-w
|
[39]
|
Lu, Z., Wang, J., Wientjes, M.G., et al. (2010) Intraperitoneal Therapy for Peritoneal Cancer. Future Oncology, 6, 1625-1641. https://doi.org/10.2217/fon.10.100
|
[40]
|
杨肖军, 熊斌. 腹腔热灌注化疗在胃肠道恶性肿瘤腹膜转移中的应用[J]. 临床外科杂志, 2019, 27(5): 443-446.
|
[41]
|
梁寒. 腹腔热灌注化疗技术临床应用专家共识(2016版)解读——胃癌腹膜转移的防治[J]. 临床外科杂志, 2017, 25(1): 20-23.
|
[42]
|
Fidler, I.J. (2003) The Pathogenesis of Cancer Metastasis: The ‘Seed and Soil’ Hypothesis Revisited. Nature Reviews Cancer, 3, 453-458. https://doi.org/10.1038/nrc1098
|
[43]
|
Sugarbaker, P.H., Yu, W. and Yonemura, Y. (2003) Gastrectomy, Peritonectomy, and Perioperative Intraperitoneal Chemotherapy: The Evolution of Treatment Strategies for Advanced Gastric Cancer. Seminars in Surgical Oncology, 21, 233-248. https://doi.org/10.1002/ssu.10042
|
[44]
|
Ahmed, N., Riley, C., Rice, G., et al. (2005) Role of Integrin Receptors for Fibronectin, Collagen and Laminin in the Regulation of Ovarian Carcinoma Functions in Response to a Matrix Microenvironment. Clinical & Experimental Metastasis, 22, 391-402. https://doi.org/10.1007/s10585-005-1262-y
|
[45]
|
Miyazono, K., Suzuki, H. and Imamura, T. (2003) Regulation of TGF-β Signaling and Its Roles in Progression of Tumors. Cancer Science, 94, 230-234. https://doi.org/10.1111/j.1349-7006.2003.tb01425.x
|
[46]
|
Sugarbaker, P.H. (1996) Peritoneal Carcinomatosis: Natural History and Rational Therapeutic Interventions Using Intraperitoneal Chemotherapy. Cancer Treatment and Research, 81, 149-168. https://doi.org/10.1007/978-1-4613-1245-1_13
|
[47]
|
Al-Shammaa, H.A., Li, Y. and Yonemura, Y. (2008) Current Status and Future Strategies of Cytoreductive Surgery plus Intraperitoneal Hyperthermic Chemotherapy for Peritoneal Carcinomatosis. World Journal of Gastroenterology, 14, 1159-1166. https://doi.org/10.3748/wjg.14.1159
|
[48]
|
徐惠绵, 武建华. 胃癌腹膜转移机理及其临床应用的研究进展[J]. 中国肿瘤临床, 2012, 39(22): 1687-1690.
|
[49]
|
Yonemura, Y., Bandou, E., Kawamura, T., et al. (2006) Quantitative Prognostic Indicators of Peritoneal Dissemination of Gastric Cancer. European Journal of Surgical Oncology, 32, 602-606. https://doi.org/10.1016/j.ejso.2006.03.003
|
[50]
|
Kusamura, S., Kepenekian, V., Villeneuve, L., et al. (2021) Peritoneal Mesothelioma: PSOGI/EURACAN Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up. European Journal of Surgical Oncology, 47, 36-59. https://doi.org/10.1016/j.ejso.2020.02.011
|
[51]
|
Govaerts, K., Lurvink, R.J., De Hingh, I., et al. (2021) Appendiceal Tumours and Pseudomyxoma Peritonei: Literature Review with PSOGI/EURACAN Clinical Practice Guidelines for Diagnosis and Treatment. European Journal of Surgical Oncology, 47, 11-35. https://doi.org/10.1016/j.ejso.2020.02.012
|
[52]
|
Van Driel, W.J., Koole, S.N., Sikorska, K., et al. (2018) Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer. The New England Journal of Medicine, 378, 230-240. https://doi.org/10.1056/NEJMoa1708618
|
[53]
|
解亦斌, 田艳涛. 我国晚期胃癌临床特点及诊治策略[J]. 中华医学杂志, 2018, 98(24): 1897-1898.
|
[54]
|
D'angelica, M., Gonen, M., Brennan, M.F., et al. (2004) Patterns of Initial Recurrence in Completely Resected Gastric Adenocarcinoma. Annals of Surgery, 240, 808-816. https://doi.org/10.1097/01.sla.0000143245.28656.15
|
[55]
|
Seyfried, F., Von Rahden, B.H., Miras, A.D., et al. (2015) Incidence, Time Course and Independent Risk Factors for Metachronous Peritoneal Carcinomatosis of Gastric Origin—A Longitudinal Experience from a Prospectively Collected Database of 1108 Patients. BMC Cancer, 15, Article No. 73. https://doi.org/10.1186/s12885-015-1081-8
|
[56]
|
Koga, S., Hamazoe, R., Maeta, M., et al. (1988) Prophylactic Therapy for Peritoneal Recurrence of Gastric Cancer by Continuous Hyperthermic Peritoneal Perfusion with Mitomycin C. Cancer, 61, 232-237. https://doi.org/10.1002/1097-0142(19880115)61:2<232::AID-CNCR2820610205>3.0.CO;2-U
|
[57]
|
Kerkar, S.P., Kemp, C.D., Duffy, A., et al. (2009) The GYMSSA Trial: A Prospective Randomized Trial Comparing Gastrectomy, Metastasectomy plus Systemic Therapy Versus Systemic Therapy Alone. Trials, 10, Article No. 121. https://doi.org/10.1186/1745-6215-10-121
|
[58]
|
李少卿, 张珂诚, 陈凛. 胃癌腹腔热灌注化疗的现状与进展[J]. 中国普外基础与临床杂志, 2020, 27(8): 922-926.
|
[59]
|
Yonemura, Y., Kawamura, T., Bandou, E., et al. (2005) Treatment of Peritoneal Dissemination from Gastric Cancer by Peritonectomy and Chemohyperthermic Peritoneal Perfusion. British Journal of Surgery, 92, 370-375. https://doi.org/10.1002/bjs.4695
|
[60]
|
Yang, X.J., Huang, C.Q., Suo, T., et al. (2011) Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial. Annals of Surgical Oncology, 18, 1575-1581. https://doi.org/10.1245/s10434-011-1631-5
|
[61]
|
Coccolini, F., Cotte, E., Glehen, O., et al. (2014) Intraperitoneal Chemotherapy in Advanced Gastric Cancer. Meta-Analysis of Randomized Trials. European Journal of Surgical Oncology, 40, 12-26. https://doi.org/10.1016/j.ejso.2013.10.019
|
[62]
|
Bonnot, P.E., Piessen, G., Kepenekian, V., et al. (2019) Cytoreductive Surgery with or without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer with Peritoneal Metastases (CYTO-CHIP Study): A Propensity Score Analysis. Journal of Clinical Oncology, 37, 2028-2040. https://doi.org/10.1200/JCO.18.01688
|
[63]
|
Rudloff, U., Langan, R.C., Mullinax, J.E., et al. (2014) Impact of Maximal Cytoreductive Surgery plus Regional Heated Intraperitoneal Chemotherapy (HIPEC) on Outcome of Patients with Peritoneal Carcinomatosis of Gastric Origin: Results of the GYMSSA Trial. Journal of Surgical Oncology, 110, 275-284. https://doi.org/10.1002/jso.23633
|
[64]
|
Gill, R.S., Al-Adra, D.P., Nagendran, J., et al. (2011) Treatment of Gastric Cancer with Peritoneal Carcinomatosis by Cytoreductive Surgery and HIPEC: A Systematic Review of Survival, Mortality, and Morbidity. Journal of Surgical Oncology, 104, 692-698. https://doi.org/10.1002/jso.22017
|
[65]
|
Glehen, O., Gilly, F.N., Arvieux, C., et al. (2010) Peritoneal Carcinomatosis from Gastric Cancer: A Multi-Institutional Study of 159 Patients Treated by Cytoreductive Surgery Combined with Perioperative Intraperitoneal Chemotherapy. Annals of Surgical Oncology, 17, 2370-2377. https://doi.org/10.1245/s10434-010-1039-7
|
[66]
|
季加孚, 沈琳, 徐惠绵, 等. 胃癌腹膜转移防治中国专家共识[J]. 中华普通外科学文献(电子版), 2017, 11(5): 289-297.
|
[67]
|
Husain, A., Bezjak, A. and Easson, A. (2010) Malignant Ascites Symptom Cluster in Patients Referred for Paracentesis. Annals of Surgical Oncology, 17, 461-469. https://doi.org/10.1245/s10434-009-0774-0
|
[68]
|
Facchiano, E., Scaringi, S., Kianmanesh, R., et al. (2008) Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for the Treatment of Malignant Ascites Secondary to Unresectable Peritoneal Carcinomatosis from Advanced Gastric Cancer. European Journal of Surgical Oncology, 34, 154-158. https://doi.org/10.1016/j.ejso.2007.05.015
|
[69]
|
Facchiano, E., Risio, D., Kianmanesh, R., et al. (2012) Laparoscopic Hyperthermic Intraperitoneal Chemotherapy: Indications, Aims, and Results: A Systematic Review of the Literature. Annals of Surgical Oncology, 19, 2946-2950. https://doi.org/10.1245/s10434-012-2360-0
|
[70]
|
Randle, R.W., Swett, K.R., Swords, D.S., et al. (2014) Efficacy of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in the Management of Malignant Ascites. Annals of Surgical Oncology, 21, 1474-1479. https://doi.org/10.1245/s10434-013-3224-y
|
[71]
|
Yonemura, Y., Elnemr, A., Endou, Y., et al. (2010) Multidisciplinary Therapy for Treatment of Patients with Peritoneal Carcinomatosis from Gastric Cancer. World Journal of Gastrointestinal Oncology, 2, 85-97. https://doi.org/10.4251/wjgo.v2.i2.85
|
[72]
|
Gao, T., Huang, X.X., Wang, W.Y., et al. (2019) Feasibility and Safety of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy in Patients with Advanced Stage Ovarian Cancer: A Single-Center Experience. Cancer Management and Research, 11, 6931-6940. https://doi.org/10.2147/CMAR.S213882
|
[73]
|
Lee, T.Y., Liao, G.S., Fan, H.L., et al. (2021) Conversion Surgery for Patients with Advanced Gastric Cancer with Peritoneal Carcinomatosis. Journal of Oncology, 2021, Article ID: 5459432. https://doi.org/10.1155/2021/5459432
|